logo

Akcea Therapeutics Inc. (AKCA)



Trade AKCA now with
  Date
  Headline
8/7/2018 7:17:40 AM Ionis Q2 Loss Per Share $0.29 Vs Loss $0.02 Last Year
8/2/2018 8:12:24 AM Akcea Therapeutics And PTC Therapeutics Collaborate To Commercialize Two Rare Disease Drugs In Latin America
7/11/2018 7:31:29 AM Akcea And Ionis Announce Approval Of TEGSEDI In The European Union
6/5/2018 4:10:39 PM Akcea Therapeutics Appoints Richard Moscicki To Board Of Directors
6/5/2018 4:03:39 PM Ionis Pharmaceuticals Closes Strategic Collaboration With Biogen
6/1/2018 8:07:45 AM Akcea And Ionis Receive Positive EU CHMP Opinion For TEGSEDI
5/4/2018 7:04:02 AM Ionis Pharma Q1 Net Loss $10.8 Mln Vs Net Income Of $9.0 Mln Last Year
4/21/2018 12:54:12 PM Akcea Therapeutics To Present Data On Inotersen For The Treatment Of HATTR Amyloidosis